Drug Approval | November 27, 2025
SMS Pharmaceutical's associate company receives FDA approval for reformulated Ranitidine
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Enabling a new era in minimally invasive obesity treatment across Europe
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
The Fast Track Designation was supported by nonclinical data as well as clinical results from the ongoing Phase I/IIa trial evaluating the safety and tolerability
Speakers are: Ch. A. P. Rameswara Rao, National President, BDMAI; Dr. Paidi Yella Reddy, Founder, President & CEO, Sapala Organics; K. V. Rama Gopal, Site Manager & Executive Director, Clariant India; Dr. K. Nagaiah, Chief Scientist, CSIR - Indian Institute of Chemical Technology, Hyderabad; Dr. Satyanarayana Thirunahari, Senior General Manager - Process Safety & Engineering, Laurus Labs; and Yadavendra Shalgaonkar, Assistant General Manager - Tube Sales, Alleima India
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
New study presents a human-relevant stress model for assessing potential therapeutics
He has been associated with the Zydus Group since 2009
Subscribe To Our Newsletter & Stay Updated
